Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

SHA:688393 Revenue

Guangzhou LBP Medicine Science & Technology had revenue of 91.96M CNY in the quarter ending June 30, 2026, with 5.88% growth. This brings the company's total for the last twelve months to 356.56M, down -11.33% year-over-year. In the year 2025, Guangzhou LBP Medicine Science & Technology had annual revenue of 344.45M, down -26.84%. That makes Guangzhou LBP Medicine Science & Technology the 27,475th largest company in the world by revenue and 4,762nd in China.

• Revenue (ttm): 356.56M
• Revenue Growth: -11.33%
• P/S Ratio: 4.83
• Revenue / Employee: 451.34K
• Employees: 790
• Market Cap: 1.79B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 97.83M 29.0%
• South China 84.87M 25.2%
• North China 47.46M 14.1%
• Southwest China 39.40M 11.7%
• Central China 35.85M 10.6%
• Northwest China 24.80M 7.4%
• Northeast China 5.65M 1.7%
• Overseas 1.41M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHA:688393 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	344.45M	-126.34M	-26.84%
Dec 31, 2024	470.79M	-26.50M	-5.33%
Dec 31, 2023	497.29M	-10.09M	-1.99%
Dec 31, 2022	507.38M	68.39M	15.58%
Dec 31, 2021	438.99M	63.56M	16.93%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error